Point of Care Lipid Test Market to Grow with a CAGR of 6.46% through 2030
Increasing
adoption of point-of-care testing in primary care settings and technological
advancements in portable lipid analyzers, is expected to
drive the Global Point of Care Lipid Test Market growth in the forecast period,
2026-2030
According to TechSci
Research report, “Point of Care Lipid Test Market – Global Industry Size,
Share, Trends, Competition Forecast & Opportunities, 2030F”, the
Global Point of Care Lipid Test Market stood at USD 735.61 Million in 2024 and is
expected to reach USD 1072.48 Million by 2030 with a CAGR of 6.46% during the
forecast period. The Global
Point of Care Lipid Test Market is gaining momentum due to rising demand for
rapid diagnostic tools in non-laboratory settings. With the global increase in
metabolic disorders such as dyslipidemia and obesity, there is a growing
clinical need for accessible lipid profile screening at the primary care level.
Point of care lipid testing enables timely risk stratification for
cardiovascular events without the delay of centralized laboratory processing.
These diagnostic tools are becoming indispensable in rural healthcare
facilities, ambulatory clinics, and home care environments where traditional
lab infrastructure is limited. The convenience of on-the-spot testing is
helping healthcare providers make quicker decisions regarding medication
initiation, lifestyle counseling, and specialist referrals.
Emerging
trends are reshaping the market as digital health platforms increasingly
incorporate lipid monitoring devices. Integration with mobile health (mHealth)
applications allows patients and providers to track cholesterol levels, share
data in real-time, and adjust treatment protocols efficiently. Miniaturization
of diagnostic tools, combined with intuitive interfaces, is improving usability
and promoting wider acceptance. Companies are also leveraging AI-powered
analytics for better interpretation of lipid test results, aiding early
detection of complex conditions like atherosclerosis. Furthermore, growing
initiatives by governments and NGOs to promote regular cardiovascular screening
in underserved populations are encouraging broader implementation of
point-of-care diagnostics across global health systems.
Significant
growth opportunities lie in the expansion of testing capabilities beyond
traditional healthcare institutions. Collaborations between diagnostic device
manufacturers and retail pharmacy chains are opening up new distribution
channels, enhancing convenience and reach. The development of cost-effective,
disposable test kits suitable for mass screening programs is expected to
further boost demand, particularly in emerging economies. Educational campaigns
around cardiovascular risk prevention and the inclusion of lipid testing in
routine health checkup protocols are likely to stimulate sustained adoption. As
health systems globally move toward decentralization and patient-centric care
models, the market for point-of-care lipid testing is poised for robust and
sustained expansion across both developed and developing regions.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on
"Global Point of Care Lipid Test Market”
The Global Point
of Care Lipid Test Market is segmented into product, application, disease indication,
end user, regional distribution, and company.
Based on the Disease
Indication, Atherosclerosis emerged as the fastest growing segment in the Global
Point of Care Lipid Test Market during the forecast period. This is driven by
its strong association with cardiovascular diseases (CVDs) and the increasing
need for early detection. Atherosclerosis, characterized by plaque buildup in
arteries, is a leading cause of heart attacks and strokes, making rapid lipid
profiling critical for risk assessment. POC lipid tests enable immediate
measurement of LDL, HDL, and triglycerides key biomarkers for atherosclerosis allowing
clinicians to initiate timely interventions such as statin therapy or lifestyle
modifications. The growth of this segment is further fueled by rising global
prevalence of atherosclerosis risk factors, including obesity, diabetes, and
hypertension. Additionally, advancements in POC technologies have improved the
accuracy and speed of lipid testing, making them indispensable in emergency
departments, cardiology clinics, and preventive care settings.
Based
on the Region, Asia-Pacific emerged as the fastest growing region in the Global
Point of Care Lipid Test Market during
the forecast period. This is due to the increasing investment in healthcare
innovation and the adoption of advanced POC diagnostic technologies.
Multinational diagnostic companies are expanding their presence in the region,
partnering with local firms to develop cost-effective, portable lipid testing
devices tailored to Asia-Pacific’s diverse healthcare needs. Regulatory reforms
in countries like India and China have streamlined approvals for POC devices,
encouraging faster market entry. Moreover, public health campaigns promoting
preventive care and routine lipid screening have heightened awareness among
patients and physicians. The COVID-19 pandemic also underscored the importance
of decentralized testing, prompting greater adoption of POC solutions beyond
traditional hospital settings.
Major
companies operating in Global Point of Care Lipid Test Market are:
- Callegari
Srl
- Sinocare
Inc.
- Abbott
Laboratories
- MiCoBio
- Nova
Biomedical
- VivaChek
Biotech (Hangzhou) Co., Ltd.
- F.
Hoffmann-La Roche Ltd.
- Menarini
Group
- SD
Biosensor, Inc.
- Becton,
Dickinson and Company
Download Free Sample Report
Customers can
also request for 10% free customization on this report
“The Global Point of Care Lipid Test
Market is expanding due to the growing emphasis on personalized and preventive
healthcare, which has led to increased adoption of rapid diagnostic tools for
early detection and management of cardiovascular diseases. As healthcare
systems prioritize timely risk assessment and intervention, point-of-care lipid
testing enables clinicians to make quicker, evidence-based decisions,
especially in primary care and remote settings. The shift toward decentralizing
diagnostic services, coupled with technological advancements in compact,
user-friendly analyzers, is enhancing access to lipid profiling across diverse
patient populations. This trend is supported by government initiatives
promoting preventive screenings to reduce long-term healthcare costs,
particularly in aging populations prone to hyperlipidemia.,”
said Mr. Karan Chechi, Research Director of TechSci Research, a research-based
management consulting firm.
“Point of Care Lipid Test
Market - Global Industry Size, Share, Trends, Opportunity, and Forecast,
Segmented By Product (Instruments, Consumables), By Application
(Hyperlipidemia, Hypertriglyceridemia, Tangier Disease, Hyperlipoproteinemia,
Familial Hypercholesterolemia, Others), By Disease Indication (Lipid and
Lipoprotein Disorders, Atherosclerosis, Liver and Renal Diseases, Diabetes
Mellitus, Others), By End User (Hospitals, Clinics, Research and Diagnostic
Laboratories, Others), By Region and Competition, 2020-2030F”,
has evaluated the future growth potential of Global Point of Care Lipid Test
Market and provides statistics & information on market size, structure and
future market growth. The report intends to provide cutting-edge market
intelligence and help decision makers take sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in Global Point of Care Lipid
Test Market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New York,
United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com